Article
Companion gene mutations and their clinical significance in AML with double mutant CEBPA.
Cancer gene therapy - 1 Aug 2020
Zhang Yang, Wang Fang, Chen Xue, Zhang Yu, Wang Mingyu, Liu Hong, Teng Wen, Cao Panxiang, Nie Daijing, Ma Xiaoli, Wang Tong, Lu Peihua, Liu Hongxing
Abstract excerpt
Acute myeloid leukemia (AML) with double mutant CEBPA (CEBPAdm) is generally associated with favorable prognosis, but the heterogeneity still blatant and needs further exploration. We aimed to comprehensively analyze the companion genetic abnormalities and their clinical significance in AML patients with CEBPAdm. By performed targeted amplicon sequencing of 58 genes in specimens at the time of initial diagnosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
